In virology, biosensors and CRISPR/Cas systems have emerged as revolutionary technologies with immense potential for diagnosing viral infections. Biosensors play a crucial role in rapidly and sensitively identifying viral pathogens. They offer advantages such as real-time monitoring, portability, and enhanced sensitivity, making them invaluable tools in the fight against viral diseases.
Complementing biosensors, CRISPR/Cas systems, initially known for their groundbreaking gene-editing capabilities, have found applications in virology for detecting viral nucleic acids. The CRISPR/Cas technology enables precise and programmable recognition of specific DNA or RNA sequences, making it an ideal candidate for developing highly accurate diagnostic tools. In the context of viral infections, CRISPR-based systems can be harnessed to target and identify viral genetic material, allowing for rapid and specific detection of pathogens. The synergy between biosensors and CRISPR/Cas systems holds tremendous promise in revolutionizing the field of virology, offering advanced diagnostic platforms that could significantly improve the speed, accuracy, and accessibility of viral infection diagnosis.
The current Research Topic welcomes all types of scholarly work that have the potential to show novel aspects and innovations in biosensors and CRISPR/Cas systems in virology. We are interested in including studies from basic research to new applications of these new tools, but not limited to, the following areas:
• Discovery of new Cas enzymes;
• New biosensor proposals;
• Biosensors for monitoring of Real-time Viral Load;
• Biosensors and CRISPR/Cas system for the rapid diagnosis of viral infectious diseases (current and emerging);
• The use of these technologies in virology laboratories;
• Amplification-free detection methods for the diagnosis of viral infections;
• Ultrasensitive one-pot detection methods;
• Methods with the potential to democratize and simplify molecular diagnostic tests;
• Methods with characteristics such as minimally invasive, point-of-care testing, field-applicable, or naked-eye detection;
• Bioengineered Biosensors for Improved Sensitivity and Specificity;
• Collaborative Approaches in CRISPR-based Diagnostics;
• Novel systems for Enhanced Viral Diagnostics;
• The use of these technologies in various aspects, such as diagnosing emerging and re-emerging viruses, outbreaks and pandemics, chronic infections, transplants, neglected diseases, and veterinary medicine;
Keywords:
Biosensor, CRISPR, Cas, Molecular diagnostic, point-of-care testing, Molecular Virology
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
In virology, biosensors and CRISPR/Cas systems have emerged as revolutionary technologies with immense potential for diagnosing viral infections. Biosensors play a crucial role in rapidly and sensitively identifying viral pathogens. They offer advantages such as real-time monitoring, portability, and enhanced sensitivity, making them invaluable tools in the fight against viral diseases.
Complementing biosensors, CRISPR/Cas systems, initially known for their groundbreaking gene-editing capabilities, have found applications in virology for detecting viral nucleic acids. The CRISPR/Cas technology enables precise and programmable recognition of specific DNA or RNA sequences, making it an ideal candidate for developing highly accurate diagnostic tools. In the context of viral infections, CRISPR-based systems can be harnessed to target and identify viral genetic material, allowing for rapid and specific detection of pathogens. The synergy between biosensors and CRISPR/Cas systems holds tremendous promise in revolutionizing the field of virology, offering advanced diagnostic platforms that could significantly improve the speed, accuracy, and accessibility of viral infection diagnosis.
The current Research Topic welcomes all types of scholarly work that have the potential to show novel aspects and innovations in biosensors and CRISPR/Cas systems in virology. We are interested in including studies from basic research to new applications of these new tools, but not limited to, the following areas:
• Discovery of new Cas enzymes;
• New biosensor proposals;
• Biosensors for monitoring of Real-time Viral Load;
• Biosensors and CRISPR/Cas system for the rapid diagnosis of viral infectious diseases (current and emerging);
• The use of these technologies in virology laboratories;
• Amplification-free detection methods for the diagnosis of viral infections;
• Ultrasensitive one-pot detection methods;
• Methods with the potential to democratize and simplify molecular diagnostic tests;
• Methods with characteristics such as minimally invasive, point-of-care testing, field-applicable, or naked-eye detection;
• Bioengineered Biosensors for Improved Sensitivity and Specificity;
• Collaborative Approaches in CRISPR-based Diagnostics;
• Novel systems for Enhanced Viral Diagnostics;
• The use of these technologies in various aspects, such as diagnosing emerging and re-emerging viruses, outbreaks and pandemics, chronic infections, transplants, neglected diseases, and veterinary medicine;
Keywords:
Biosensor, CRISPR, Cas, Molecular diagnostic, point-of-care testing, Molecular Virology
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.